IndoStar Capital Reports 130 Crore Annual Profit but Q4 Loss Widens on Security Receipt Provisions Pokmon Card Market Heats Up Nostalgia Speculation and HighProfile Collectors Drive MillionDollar Sales RBIs Surprise Rate Cut Dilutes Monetary Policy Framework Nomura ONGC Shares Decline 35 on Q4 Results Amid Production Declines and Higher Writeoffs Rachel Reeves Cost of Living Measures MiniSteps Amid Britains Looming Energy Shock Middle East Tensions Drive Gains for Canadian Natural Resources CNQ Shenandoah Telecommunications Co Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher AVXL Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued RD Focus Weyco Group Inc WEYS Q1 2026 Earnings Solid EPS Performance Amidst Quiet Quarter ADAMH Q1 2026 Earnings Senior Notes Trust Beats EPS Estimate by 75 Shares Edge Higher Scienture Holdings Inc SCNX Q1 2026 Earnings Narrowerthanexpected loss drives positive surprise BEKE Q1 2026 Earnings EPS Misses Estimates Stock Declines GlucoTrack Inc GCTK Rallies 823 as Shares Test Key Resistance Level Ichor Holdings ICHR Gains 139 as Shares Approach Resistance Marti Technologies MRT Slips 2 as Stock Tests Support Near 184 Knowles Corporation KN Surges 387 as Stock Approaches Key Resistance Level Oportun Financial Corporation OPRT Inches Higher Testing Key Resistance Levels Equifax Stock Wall Street Sentiment Weighs Bullish and Bearish Views Regional Management Corp RM Q1 2026 Earnings EPS Beats Estimates by 175 as Stock Retreats SolarEdge Surges 148 Whats Driving the Solar Stocks Rally Ambow Education Q1 2012 Earnings Massive EPS Miss Sends Shockwaves Yet Stock Rises 38 GKOS Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Shares Alpha Cognition Inc Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Clinical Progress ASND Q1 2026 Earnings EPS Misses Estimates as Ascendis Pharma Navigates Cost Pressures Aurora Mobile Q4 2025 Earnings Profitability Achieved Despite Revenue Headwinds CMMB Q1 2026 Earnings Missed EPS Estimates but Stock Gains on Continued Pipeline Progress Dianthus Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline